Skip to main content

Table 2 Clinical and biochemical characteristics and ectopic fat depots according to MetS

From: Perirenal fat thickness and liver fat fraction are independent predictors of MetS in adults with overweight and obesity suspected with NAFLD: a retrospective study

Characteristics

n

Patients with MetS(n = 63)

Patients without MetS(n = 71)

p value

PRFT (mm)

134

13.17 (7.70)

10.35 (6.78)

0.026

SATT (mm)

134

27.53 (10.07)

31.19 (10.12)

0.038

Age (y)

134

33.06(9.20)

30.11(8.97)

0.063

BMI (kg/m2)

134

33.77(4.56)

34.12(4.93)

0.668

Waist circumference (cm)

134

107.46(10.86)

106.30(12.09)

0.584

Fasting insulin (pmol/L)

134

236.80(127.52)

207.23 (117.51)

0.165

HOMA-IR

134

9.81 (6.86)

7.09 (4.72)

0.009

ALT (U/L)

134

84.27 (60.72)

58.44 (45.74)

0.006

AST (U/L)

134

51.00 (36.46)

36.34 (26.32)

0.008

LFF (%)

134

20.70(10.50)

14.18 (8.92)

< 0.001

PFF (%)

133

6.67 (6.25)

5.20(4.39)

0.114

Pancreas head fat fraction (%)

133

4.02(3.44)

3.05(3.06)

0.086

Pancreas body fat fraction (%)

133

5.96(7.20)

4.51(4.31)

0.157

Pancreas tail fat fraction (%)

133

10.05(10.65)

8.03(8.0)

0.217

LSFF (%)

134

42.12(9.82)

40.82 (9.62)

0.440

  1. Data are presented as mean (SD) or percentage. Results were based on analyses according to the MetS of the general population.
  2. MetS metabolic syndrome, PRFT perirenal fat thickness, SATT subcutaneous adipose tissue thickness, HOMA-IR homeostasis model assessment of insulin resistance, ALT alanine transaminase, AST aspartate transaminase, LFF liver fat fraction, PFF pancreas fat fraction, LSFF lumbar spine fat fraction.